What is EGCG?

EGCG is a flavan-3-ol catechin polyphenol and the primary bioactive compound in green tea (Camellia sinensis), comprising up to 50–80% of the total catechin content in brewed green tea. It is isolated and concentrated in standardized green tea extract supplements, allowing doses far exceeding what is achievable through tea consumption alone. EGCG has been the subject of extensive human clinical research since the 1990s, making it one of the most studied plant polyphenols in nutrition science.

How does EGCG work?

EGCG acts as a potent antioxidant, directly scavenging reactive oxygen species (ROS) and upregulating endogenous antioxidant enzymes such as superoxide dismutase and catalase. It modulates multiple intracellular signaling pathways including AMPK activation (promoting fat oxidation and glucose uptake), inhibition of NF-κB (reducing inflammatory cytokine production), and inhibition of DNMT1 (influencing gene expression through epigenetic mechanisms). EGCG also inhibits catechol-O-methyltransferase (COMT), an enzyme that degrades catecholamines like norepinephrine, thereby amplifying thermogenic signaling in adipose tissue.

What forms does EGCG come in?

Capsules of standardized green tea extract (typically 400–800 mg extract per capsule providing 200–600 mg EGCG) are the most clinically studied delivery format. Matcha powder provides the highest EGCG per serving among beverage sources. Decaffeinated green tea extract is available for those caffeine-sensitive. Powder forms allow flexible dosing but have a notably astringent taste.

Where it comes from:

Green tea has been consumed in China for over 3,000 years and was documented in the Tang Dynasty pharmacopeia (7th century CE) for its stimulating, digestive, and clarifying properties. Japanese Zen Buddhist monks adopted it in the 12th century to support meditation. The isolation of EGCG as the primary bioactive catechin was accomplished by Japanese chemists in the mid-20th century, and large-scale human clinical research accelerated from the 1990s onward, particularly in Japan and increasingly in Western institutions.

What does EGCG help with?

• Weight Management / Metabolic Syndrome: EGCG inhibits COMT, reducing the breakdown of norepinephrine and thereby prolonging thermogenic signaling in brown and white adipose tissue. A meta-analysis by Hursel et al. (2009, International Journal of Obesity, pooling data from 11 RCTs) found that green tea catechins combined with caffeine produced a statistically significant reduction in body weight and maintenance of weight loss compared to caffeine alone or control. A subsequent Cochrane-style systematic review by Jurgens et al. (2012, Cochrane Database of Systematic Reviews) examining 14 RCTs confirmed modest but significant reductions in body weight and BMI, with effects most pronounced in Asian populations, possibly due to COMT genotype differences. Effect sizes are modest (typically 1–3 kg over 12 weeks) but are clinically meaningful in a metabolic syndrome context.
• Cardiovascular Health: EGCG reduces LDL oxidation by directly scavenging lipid peroxyl radicals and chelating redox-active metals, a key early step in atherosclerotic plaque formation. A meta-analysis by Zheng et al. (2011, European Journal of Clinical Nutrition, 14 RCTs) found significant reductions in total cholesterol and LDL cholesterol with green tea catechin supplementation, with no significant effect on HDL. Additionally, large prospective cohort studies in Japanese populations (notably the Ohsaki Cohort Study, Kuriyama et al., 2006, JAMA, n=40,530) showed that higher green tea consumption was inversely associated with cardiovascular disease mortality, though this is observational evidence.
• Blood Sugar Regulation (Type 2 Diabetes Risk): EGCG activates AMPK in skeletal muscle and liver, mimicking some effects of exercise on glucose transporter (GLUT4) translocation and improving insulin sensitivity. A meta-analysis by Liu et al. (2014, American Journal of Clinical Nutrition, 22 RCTs) found green tea supplementation significantly reduced fasting blood glucose and HbA1c levels, with the largest effects in populations at elevated metabolic risk. EGCG also inhibits intestinal glucose transporters (SGLT1 and GLUT2), slowing postprandial glucose absorption, which contributes to blunted glycemic response after meals.
• Cognitive Function and Neuroprotection: EGCG crosses the blood-brain barrier and modulates neurotrophin signaling, including upregulation of BDNF, which supports synaptic plasticity and neuronal survival. It also inhibits beta-amyloid aggregation in vitro and has been studied in early human trials for neurodegenerative conditions. A randomized, double-blind trial by Yoo et al. (2020, Nutrients) in healthy older adults found that 12 weeks of EGCG supplementation improved scores on working memory and attention tasks compared to placebo. Population-level associations between regular green tea consumption and reduced risk of cognitive decline have been reported in multiple Japanese cohort studies (e.g., Kuriyama et al., 2006, American Journal of Clinical Nutrition, n=1,003 elderly adults), though causality remains to be definitively established.
• Inflammation: EGCG suppresses NF-κB activation by blocking IκB kinase, reducing transcription of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β. In a double-blind RCT by Bogdanski et al. (2012, Nutrition Research, n=56 obese hypertensive adults), 3 months of green tea extract supplementation significantly reduced circulating CRP, TNF-α, and IL-6 versus placebo. These anti-inflammatory effects are considered mechanistically foundational to EGCG's cardiovascular, metabolic, and neuroprotective benefits.
• Liver Health (Non-Alcoholic Fatty Liver Disease): EGCG activates AMPK in hepatocytes, reducing de novo lipogenesis and promoting fatty acid beta-oxidation, directly addressing hepatic fat accumulation in NAFLD. A randomized controlled trial by Sakata et al. examining green tea extract supplementation in patients with elevated liver enzymes found significant reductions in ALT and AST. Multiple systematic reviews have noted the hepatoprotective potential of green tea catechins in NAFLD, though the same EGCG doses in high-potency supplements (above 800 mg/day) paradoxically risk hepatotoxicity, meaning therapeutic window monitoring is important. VERIFY_NAME_IN_ADMIN: NAFLD / Non-Alcoholic Fatty Liver Disease

What can EGCG help prevent?

• Oxidative stress-related cellular damage (well-supported by RCT biomarker data showing reduction in 8-OHdG and F2-isoprostanes)
• Cardiovascular disease mortality (supported by large prospective cohort data, particularly Ohsaki Cohort Study, Kuriyama et al., 2006, JAMA)
• Progression from impaired fasting glucose to type 2 diabetes (supported by glucose and HbA1c reduction data across multiple RCTs)

Which foods are rich in EGCG?

1. Matcha (powdered green tea): Whole-leaf consumption delivers the highest EGCG per serving of any beverage — estimates range from 70–130 mg EGCG per gram of matcha, significantly higher than steeped green tea because the entire leaf is consumed.
2. Gyokuro green tea (brewed): Shade-grown Japanese green tea with among the highest catechin concentrations of any steeped tea; a single cup provides approximately 60–90 mg EGCG, higher than standard green tea due to reduced oxidation and growing conditions.
3. Sencha green tea (brewed): The most commonly consumed green tea globally; a standard 8 oz cup provides approximately 30–60 mg EGCG depending on steeping time, temperature, and leaf quality — represents the baseline dietary EGCG source for most populations.
4. Oolong tea (partially oxidized): Partial oxidation converts some catechins to theaflavins and thearubigins, but oolong retains meaningful EGCG levels (approximately 15–30 mg per cup), making it a secondary dietary source with its own complementary polyphenol profile.
5. White tea (brewed): Minimally processed from young Camellia sinensis buds, white tea retains a moderate catechin content including EGCG (approximately 15–25 mg per cup) and is notable for its very low caffeine content relative to its polyphenol load.

Practical Tips:

All direct food sources of EGCG are derived from Camellia sinensis (the tea plant). Maximum dietary EGCG intake through tea consumption is approximately 100–200 mg/day for heavy tea drinkers — below the 400–800 mg/day doses used in most clinical supplementation trials. Supplemental EGCG is required to replicate therapeutic trial doses. Avoid consuming EGCG-rich teas with dairy milk, as casein proteins may bind catechins and reduce bioavailability; lemon juice (vitamin C) enhances bioavailability.

What are the side effects of EGCG?

• Nausea and gastrointestinal upset (most common, particularly on an empty stomach; dose-dependent)
• Elevated liver enzymes / hepatotoxicity (rare but documented at high doses above 800 mg/day EGCG; reversible upon discontinuation in most cases)
• Insomnia and jitteriness (when non-decaffeinated green tea extract is used)
• Headache (reported in early dosing, likely caffeine-related in non-decaffeinated products)
• Reduced iron absorption (especially relevant with iron-deficient individuals; chelation effect)
• Mild hypotension or heart palpitations at very high doses
• Skin rash (rare hypersensitivity reactions)

Good to know:

EGCG from dietary green tea consumption is very well tolerated across populations with a long safety record spanning centuries. Supplemental EGCG at doses above 400–800 mg/day (particularly taken fasted) carries a documented risk of nausea, GI distress, and — rarely — hepatotoxicity. The European Food Safety Authority (2018) concluded that single doses of EGCG above 800 mg/day may be associated with liver injury risk, and the FDA has received adverse event reports linked to high-potency green tea extract products. Most adverse effects are dose-dependent and resolve with dose reduction or discontinuation.

How much EGCG should you take?

• Recommended daily: 400–800 mg/day of EGCG (as standardized green tea extract providing at least 45% EGCG). Most positive RCTs used 400–600 mg/day. The European Food Safety Authority has flagged single doses above 800 mg/day as potentially hepatotoxic. Start at the lower end (400 mg/day) and assess tolerance.
• Best time of day: Morning or early afternoon. Caffeine-containing green tea extracts can disrupt sleep if taken in the evening. Some protocols split the dose (morning and midday) to maintain plasma catechin levels.
• With or without food: Take with food to significantly reduce risk of nausea and GI upset. Note that high-fat meals may modestly reduce EGCG absorption, so a light meal is preferred. Avoid taking within 1–2 hours of iron-rich foods or iron supplements to prevent chelation-mediated absorption interference.
• Time to effect: Acute antioxidant and thermogenic effects within 1–2 hours of dosing; sustained metabolic benefits (weight, lipids, glucose) require 8–12 weeks of consistent daily use.
• How long to take it: Most trials run 8–16 weeks continuously. Long-term daily use beyond 6 months at doses above 600 mg/day EGCG is not well-studied for safety. Periodic breaks (e.g., cycling 8–12 weeks on, 4 weeks off) are a reasonable precautionary approach for isolated high-dose EGCG supplementation. Dietary consumption of green tea carries no cycling requirement.